Publicacións (14) Publicacións de Isabel Santamarina Cainzos

2018

  1. Hakai overexpression effectively induces tumour progression and metastasis in vivo

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System

    Journal of Proteome Research, Vol. 16, Núm. 8, pp. 2773-2788

2015

  1. Circulating miR-200c and miR-141 and outcomes in patients with breast cancer

    BMC Cancer, Vol. 15, Núm. 1

2012

  1. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

    Journal of Translational Medicine, Vol. 10, Núm. 1

  2. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer

    International Journal of Molecular Sciences, Vol. 13, Núm. 4, pp. 4367-4387

2011

  1. Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer

    International Journal of Oncology, Vol. 39, Núm. 5, pp. 1253-1264

2010

  1. Biological correlation of the expression EGFR pathway in renal cell carcinoma with Hif1-a, VEGF, VEGFR-2(Flk-1), TGF-a, VHL in tumor tissue sample levels

    EJC SUPPLEMENTS

  2. Evaluation of Plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients

    Cancer Epidemiology Biomarkers and Prevention, Vol. 19, Núm. 6, pp. 1432-1440

2009

  1. MicroRNAs as circulating tumor cells biomarkers in gastrointestinal cancer

    EJC SUPPLEMENTS

2008

  1. Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer

    Cancer Detection and Prevention, Vol. 32, Núm. 3, pp. 236-250

  2. Diagnosis value of EGFR gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

  3. Effectiveness of COX2 inhibitor treatment in patients with dysplastic oral leukoplakia

    EJC SUPPLEMENTS

  4. Utility of p53 gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

2005

  1. The serum level of xenoantibodies, and hDAF or αgAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage

    Transplantation Proceedings